Glucocorticoid-induced osteoporosis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Start oral bisphosphonate with bone protection advice
Glucocorticoid exposure plus high fracture risk and osteoporotic BMD warrants antiresorptive treatment, commonly an oral bisphosphonate if suitable. Waiting for a fracture is inappropriate prevention. Denosumab requires a long-term plan because stopping without follow-on therapy can cause rebound vertebral fractures.
Reference: NICE CG146; NOGG osteoporosis guideline